Fremont, CA, United States of America

Arathi Sundaram

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Arathi Sundaram: Innovator in Pharmaceutical Compounds

Introduction

Arathi Sundaram is an esteemed inventor based in Fremont, CA. With a total of four patents to his name, he has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target specific dopamine receptors.

Latest Patents

Arathi's latest patents focus on Dor antagonist compounds and their pharmaceutical compositions. These innovations encompass a formula which includes pharmaceutically acceptable salts and isomers, designed to address conditions mediated by the dopamine Dor receptor. The patents not only detail the compounds but also provide methods for their synthesis and therapeutic applications.

Career Highlights

Throughout his career, Arathi has worked with innovative companies in the biopharmaceutical industry, including Altos Therapeutics and Vicuron Holdings. His work in these organizations has allowed him to apply his inventions in real-world applications, further advancing the field.

Collaborations

Arathi Sundaram has collaborated with notable professionals such as Gary W. Luehr and Priyadarshini Jaishankar. These partnerships have played a crucial role in enhancing the development and commercialization of his patentable innovations.

Conclusion

Arathi Sundaram continues to exemplify ingenuity in the pharmaceutical sector. His contributions not only enrich scientific understanding but also pave the way for novel treatments in medicine. With ongoing advancements and collaborations, the impact of his work will undoubtedly resonate for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…